Sanofi To Decide Soon Whether To Seek U.S. Approval For Dengvaxia Despite Safety Concerns In Philippines
Reuters: Sanofi may seek U.S. approval for Dengvaxia despite Philippines outrage
“Sanofi will decide shortly whether to seek regulatory approval for its dengue vaccine Dengvaxia in the United States and remains committed to the medicine despite a health scare in the Philippines, a senior executive said on Wednesday…” (Blamont, 3/7).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.